Treatment Options for Sleep Disturbances in Dementia: A Systematic Review
Open Access
- 23 March 2026
- journal article
- review article
- Published by SAGE Publications in Journal of Geriatric Psychiatry and Neurology
- Vol. 40 (1) , 3-16
Abstract
Objective: This systematic review aims to evaluate recent evidence on interventions for sleep disturbances in dementia, a major clinical concern, with limited pharmacological and non-pharmacological strategies examined in controlled trials. Methods: We included eight RCTs (N = 666 participants; 2020 – January 2025) in people with dementia and sleep disturbances. Records were identified via MEDLINE, screened using PRISMA-guidelines, and non-randomized or non-intervention studies were excluded. Risk-of-bias was assessed with Cochrane RoB2, and effect sizes (Cohen’s d) were calculated in R. Results: Z-drugs indicated small-large benefits, with eszopiclone significantly improving sleep efficiency and latency. Orexin receptor antagonists indicated mixed evidence, with low-dose lemborexant (2.5 mg) most favorable, meeting benchmarks for nocturnal awakenings. Circadian modulation light therapy was associated with reduced nocturnal awakenings in small trials, while relaxation-based music therapy indicated little to no effect. Social stimulation with PARO indicated increased sleep time and large positive effects on sleep efficiency, despite missing clinical benchmarks. Conclusions: Evidence is limited by sparse reporting and few trials per intervention. Z-drug eszopiclone, low-dose ORA lemborexant, and social stimulation PARO show the most favorable profile across outcomes and benchmarks, but pharmacological options require careful risk–benefit consideration. Non-pharmacological approaches appear safer but under-researched. Future trials should standardize outcomes and tailor strategies to patient needs. No external funding. The review was registered in INPLASY: https://doi.org/10.37766/inplasy2025.1.0097 .Keywords
This publication has 58 references indexed in Scilit:
- Prodromal dementia with Lewy bodies in REM sleep behavior disorder: A multicenter studyAlzheimer's & Dementia, 2023
- Non-pharmacological interventions for sleep disturbances in people with dementiaCochrane Database of Systematic Reviews, 2023
- Effects of eszopiclone on sleep quality and cognitive function in elderly patients with Alzheimer's disease and sleep disorder: A randomized controlled trialBrain and Behavior, 2022
- Pharmacotherapies for sleep disturbances in dementiaCochrane Database of Systematic Reviews, 2020
- Risk‐of‐bias VISualization (robvis): An R package and Shiny web app for visualizing risk‐of‐bias assessmentsResearch Synthesis Methods, 2020
- Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trialAlzheimer's & Dementia, 2020
- Light therapy for preventing seasonal affective disorderCochrane Database of Systematic Reviews, 2019
- Orexin and Alzheimer’s Disease2016
- Music for insomnia in adultsCochrane Database of Systematic Reviews, 2015
- Double blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementiaInternational Journal of Geriatric Psychiatry, 2002